These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 16337092)

  • 121. Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
    Herrera A; Muñoz P; Steinbusch HWM; Segura-Aguilar J
    ACS Chem Neurosci; 2017 Apr; 8(4):702-711. PubMed ID: 28233992
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Noradrenergic mechanisms in neurodegenerative diseases: a theory.
    Marien MR; Colpaert FC; Rosenquist AC
    Brain Res Brain Res Rev; 2004 Apr; 45(1):38-78. PubMed ID: 15063099
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs.
    Bassani TB; Vital MA; Rauh LK
    Arq Neuropsiquiatr; 2015 Jul; 73(7):616-23. PubMed ID: 26200058
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?
    Witte ME; Geurts JJ; de Vries HE; van der Valk P; van Horssen J
    Mitochondrion; 2010 Aug; 10(5):411-8. PubMed ID: 20573557
    [TBL] [Abstract][Full Text] [Related]  

  • 125. A secret that underlies Parkinson's disease: The damaging cycle.
    Sun F; Deng Y; Han X; Liu Q; Zhang P; Manzoor R; Ma H
    Neurochem Int; 2019 Oct; 129():104484. PubMed ID: 31173779
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review.
    Waggie KS; Kahle PJ; Tolwani RJ
    Lab Anim Sci; 1999 Aug; 49(4):358-62. PubMed ID: 10480639
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Etiology of Parkinson's disease: current concepts.
    Duvoisin RC
    Clin Neuropharmacol; 1986; 9 Suppl 1():S3-21. PubMed ID: 2423234
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease.
    Litim N; Morissette M; Di Paolo T
    Neurosci Biobehav Rev; 2016 Aug; 67():79-88. PubMed ID: 26708712
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
    Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
    Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Calcium, ageing, and neuronal vulnerability in Parkinson's disease.
    Surmeier DJ
    Lancet Neurol; 2007 Oct; 6(10):933-8. PubMed ID: 17884683
    [TBL] [Abstract][Full Text] [Related]  

  • 131. A one-hit model of cell death in inherited neuronal degenerations.
    Clarke G; Collins RA; Leavitt BR; Andrews DF; Hayden MR; Lumsden CJ; McInnes RR
    Nature; 2000 Jul; 406(6792):195-9. PubMed ID: 10910361
    [TBL] [Abstract][Full Text] [Related]  

  • 132. The role of glial reaction and inflammation in Parkinson's disease.
    Hirsch EC; Breidert T; Rousselet E; Hunot S; Hartmann A; Michel PP
    Ann N Y Acad Sci; 2003 Jun; 991():214-28. PubMed ID: 12846989
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease.
    Kaur K; Gill JS; Bansal PK; Deshmukh R
    J Neurol Sci; 2017 Oct; 381():308-314. PubMed ID: 28991704
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Liver enzyme abnormalities in Parkinson's disease.
    Tanner CM
    Geriatrics; 1991 Aug; 46 Suppl 1():60-3. PubMed ID: 1894148
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Parkinson's disease and enhanced inflammatory response.
    Stojkovska I; Wagner BM; Morrison BE
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1387-95. PubMed ID: 25769314
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Neuroprotective role of testosterone in the nervous system.
    Białek M; Zaremba P; Borowicz KK; Czuczwar SJ
    Pol J Pharmacol; 2004; 56(5):509-18. PubMed ID: 15591638
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Glia: initiators and progressors of pathology in Parkinson's disease.
    Halliday GM; Stevens CH
    Mov Disord; 2011 Jan; 26(1):6-17. PubMed ID: 21322014
    [TBL] [Abstract][Full Text] [Related]  

  • 138. A tale on animal models of Parkinson's disease.
    Bezard E; Przedborski S
    Mov Disord; 2011 May; 26(6):993-1002. PubMed ID: 21626544
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Extracellular proteases and neuronal cell death.
    Siao CJ; Tsirka SE
    Cell Mol Biol (Noisy-le-grand); 2002 Mar; 48(2):151-61. PubMed ID: 11990450
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Neurotrophic factors for the treatment of Parkinson's disease.
    Sullivan AM; Toulouse A
    Cytokine Growth Factor Rev; 2011 Jun; 22(3):157-65. PubMed ID: 21689963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.